Tethered cord syndrome is associated with motor and sensory deficits.
Our objective was to summarize evidence regarding the diagnosis, prophylactic surgery, symptomatic treatment, and repeat surgery of tethered spinal cord in a systematic review (CRD42023461296).
We searched 13 databases, reference-mined reviews, and contacted authors to identify diagnostic accuracy studies and treatment studies published until March 2024.
One reviewer abstracted data, and a content expert checked the data for accuracy. We assessed the risk of bias, strength of evidence (SoE), and applicability.
The evidence base includes 103 controlled studies, many with risk of bias and applicability concerns, and 355 case series providing additional clinical information. We found moderate SoE for MRI diagnosing tethered spinal cord, with medium to high diagnostic sensitivity and specificity. A small number of prophylactic surgery studies suggested motor function benefits and stability of neurologic status over time, but also complications such as surgical site infection (low SoE). A larger body of evidence documents treatments for symptomatic patients; studies revealed improvement in neurologic status after surgical detethering (low SoE), but also postoperative complications such as cerebrospinal fluid leakage (moderate SoE). A small body of evidence exists for retethering treatment (low or insufficient SoE for all outcomes).
There was insufficient evidence for key outcomes (eg, over- or undertreatment, clinical impact of diagnostic modalities, ambulation, quality of life).
This comprehensive overview informs difficult clinical decisions that parents and their children with tethered spinal cords, as well as their health care providers, face.
Tethered cord syndrome is a clinical disorder associated with motor and sensory deficits involving the cauda equina and spinal cord. Most patients present in childhood, adolescence, or early adulthood because of the congenital nature of spinal dysraphism disorders. The condition is thought to occur as a result of different pathophysiologic mechanisms resulting in spinal cord and nerve tension. A proposed pathophysiology is the ischemic hypothesis, in which chronic tension on the spinal cord and nerves leads to impaired local blood flow, local spinal cord ischemic injury, and neuronal damage.1–6 Much of the hypothesis is supported by animal models, which are often insufficient to mimic human conditions. In vivo, the degree of tension on the conus medullaris and filum terminale in tethered spinal cord patients has never been measured. In addition, no alteration in blood flow has been measured or observed in patients with tethered spinal cords, compared with healthy controls, and there is no histologic evidence of chronic ischemic injury.
Clinical assessments and imaging are the primary modalities for diagnosing tethered cord syndrome. Patients with symptomatic tethered spinal cords often present with pain, motor or sensory dysfunction, or bladder and bowel disturbances. Classically, these symptoms worsen with flexion of the spine in patients with symptomatic tethered spinal cords. Additionally, patients with spina bifida occulta-related spinal dysraphism may have cutaneous stigmata that include tufts of hair, nevi, lipoma, dermal sinuses, or hemangiomas. When patients become symptomatic with motor or sensory deficits, there is concern that neurologic injury may progress and eventually become irreversible. Most research has supported the natural history of neurologic decline in tethered spinal cords; however, the notion that patients with tethered spinal cords will surely progress and deteriorate with further motor or sensory loss may not be true for all patients.7,8
Although patients with symptomatic tethered spinal cords may benefit from surgical treatment, the likely time course and severity of progression for neurologic injuries is not well understood. Some patients progress rapidly, with significant neurologic injuries, whereas others may have a more insidious course with gradual stepwise neurologic decline. On the other hand, neurologic injury and other complications associated with surgical treatment can be quite high.9 Therefore, the potential benefits of any surgical treatment of a tethered spinal cord, particularly prophylactic surgery for asymptomatic or marginally symptomatic patients, should be carefully explored, including the possible complications and adverse effects of surgery.
With this systematic review, we address the diagnosis, surgical treatment in asymptomatic patients, treatment options in symptomatic patients, and management of patients experiencing retethering.
Methods
With this review, we followed the Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center methods detailed in a publicly available protocol.10,11 We refined the key questions with the help of interest holders in key informant interviews. A multidisciplinary technical expert panel supported the review throughout and provided input on outcome prioritization. A draft evidence report of the findings was published on the AHRQ Web site to elicit public comments. The results of this review are aimed to support a Congress of Neurologic Surgeons clinical practice guideline.
Data Sources and Searches
For primary research studies, we searched PubMed (biomedical literature), Embase (pharmacology emphasis), CINAHL (allied nursing), Web of Science (technical innovation), and SCOPUS (general research). We searched US and international research registries (clinicaltrials.gov, ICTRP) to capture a complete record of adverse events. We used existing reviews for reference mining, which were identified through the same databases used for primary research, plus the Cochrane Database of Systematic Reviews and PROSPERO. We searched for clinical practice guidelines using the ECRI repository, G-I-N, MagicApp, and ClinicalKey. We reviewed the literature suggested by peer reviewers, public posting of the draft evidence report, submissions through the Supplementary Evidence and Data for Systematic Reviews portal to AHRQ, or responses to a Federal Register notice. The search strategies are documented in the Supplemental Information.
Study Selection
We used detailed pre-established criteria to determine the eligibility of publications, as outlined in the Supplemental Information and summarized as follows:
Diagnosis: Studies of patients assessing for tethered spinal cord, evaluating screening and diagnostic approaches, tools, and criteria, such as physical examination, urodynamic studies, MRI, myelography, computed tomography (CT), or ultrasound, and revealing diagnostic performance, adverse events of diagnostic procedures, or clinical impact of the diagnosis.
Prophylactic surgery: Studies of patients with tethered spinal cords and no symptoms or those who are marginally symptomatic without functional deficits undergoing prophylactic surgery and reporting on patient health outcomes and other patient effects such as quality of life.
Symptomatic treatment: Studies of patients with symptomatic tethered spinal cords, evaluating surgical or non-surgical treatment or management interventions, such as surgical detethering, or other surgery (eg, spine-shortening vertebral osteotomy, spinal cord transection), physical therapy, bladder therapy for bladder function, or bracing, and revealing patient health outcomes and other patient effects, such as quality of life.
Repeat tethering: Studies of patients who experienced retethering after previous spinal detethering surgery, evaluating surgical interventions, and revealing patient health outcomes and other patient effects, such as quality of life.
The authors of diagnostic studies had to report on a reference standard, and the authors of treatment studies had to report on a concurrent control group that either received no or an alternative intervention to be eligible for inclusion. Studies without reference standards or control groups were retained as a resource for clinicians but did not contribute to the evidence statements because of study limitations (see Supplemental Information).
To reduce reviewer errors and bias, all citations were reviewed by a human reviewer supported by a machine learning algorithm. Citations that were deemed potentially relevant were obtained as full text. Each full-text article was independently reviewed by 2 independent literature reviewers; disagreements were resolved through consensus. Publications involving the same participants were consolidated into 1 study record.
Data Extraction and Quality Assessment
We abstracted details on the study, participant, intervention, comparator, outcome, and results. We contacted all authors of eligible studies and asked for any additional data relevant to the review. We assessed bias on the basis of patient selection, index test, reference standard, and flow of timing for diagnostic studies.12 We assessed the selection, performance, attrition, detection, reporting, and other sources of bias for treatment studies.13
Data Synthesis and Analysis
The following 4 key questions guided the synthesis: Key question 1: What is the accuracy of radiographic and other diagnostic criteria in diagnosing tethered spinal cord? Key question 2: What are the benefits and harms of prophylactic surgery for asymptomatic tethered spinal cord patients? Key question 3: What are the effectiveness, comparative effectiveness, and harms of surgical and non-surgical treatments for symptomatic tethered spinal cord? Key question 4: Among individuals who experience retethering after spinal detethering surgery, what are the benefits, harms, and long-term outcomes of another surgery, compared with no treatment?
We selected key outcomes with the help of the technical expert panel, considering clinical relevance and importance to patients to guide medical practice. We calculated effect sizes when possible and determined the feasibility of a meta-analysis for each intervention and outcome. We considered study limitations, consistency, directness, precision, and reporting bias to determine the following 4 strength of evidence (SoE) categories: high, moderate, low, or insufficient. We assessed the applicability and generalizability to current US clinical practice by evaluating patient, intervention, and setting factors.
Results
With the searches, we identified 6285 citations (see Fig 1). Of these, we obtained 2005 as full-text studies. In total, 103 controlled studies met the inclusion criteria (see the Supplemental Information for the list of included studies). In addition, 355 case series provide further clinical information on the evaluated tests and interventions, but these did not contribute to the evidence statements because of study limitations. In total, 154 publications were retained as background and reference mined. The risk of bias and applicability concerns are documented in the Supplemental Information. In the following sections, we have summarized the main findings for the key questions.
Key Question 1: Diagnosing Tethered Spinal Cord
We identified 59 diagnostic studies. The studies were conducted in 18 countries, the majority of which were US-based. The studies were generally small but ranged from 4 participants to a large-scale retrospective review of 3884 patient records.14 The studies included participants of different ages, one-third of which were exclusively pediatric patients. The main potential source of bias across the studies concerned patient selection. Most applicability concerns were associated with the patient population, either because the study included patients who were more complex (eg, all had severe neurologic symptoms) or the eligibility criteria were much narrower than those seen in usual practice.
The tests evaluated in the studies included the use of MRI, ultrasound, CT, myelography, evoked potentials, urodynamic studies, and intraoperative neurophysiological monitoring. The authors of MRI studies evaluated different sequencing modalities.15 The authors of most studies did not report concrete diagnostic accuracy measures, such as sensitivity or specificity. The authors of multiple older studies reported on the advantages of using MRI for the diagnosis of tethered spinal cords because of the achieved visual quality.
The reported sensitivity for MRI ranged from 99%16 to 62% (corresponding specificity 61%).17 The reported specificity ranged from 100% (corresponding sensitivity 93%)18 to 61% (corresponding sensitivity 62%).17 We downgraded SoE because of imprecision, given the wide range of reported results. The results for ultrasounds were also variable; the reported sensitivity ranged from 96% (corresponding specificity 96%)19 to 36% (corresponding specificity 84%;20 low SoE). The reported specificity ranged from 96% (corresponding sensitivity 96%)19 to 84% (corresponding sensitivity 36%;20 moderate SoE). Additional results are shown in Table 1.
Diagnostic Test . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
MRI | Sensitivity | 5 studies15–18,78 | Reported sensitivity ranged from 99% (no corresponding specificity) to 62% (corresponding specificity 61%) | Moderate for medium to high sensitivity |
Ultrasound | Sensitivity | 3 studies19,20,69 | Reported sensitivity ranged from 96% (corresponding specificity 96%) to 36% (corresponding specificity 100%) | Low for medium to high sensitivity |
Evoked Potentials | Sensitivity | 3 studies70–72 | Reported sensitivity ranged from 100% (no corresponding specificity) to 83% | Low for medium sensitivity |
MRI | Specificity | 4 studies15,17,18,78 | Reported specificity ranged from 100% (corresponding specificity 93%) to 61% (corresponding specificity 62%) | Moderate for medium to high specificity |
Ultrasound | Specificity | 3 studies19,20,69 | Reported specificity ranged from 96% (corresponding specificity 96%) to 84% (corresponding specificity 36%) | Moderate for medium to high specificity |
Evoked potentials | Specificity | 2 studies71,72 | Reported specificity ranged from 97% (corresponding sensitivity 83%) to 74% (corresponding sensitivity 88%) | Low for medium specificity |
MRI | Rater agreement | 1 study17 | κ between 2 evaluators was 0.94 | Insufficient |
Ultrasound | Rater agreement | 2 studies73,74 | ICC ranged from 0.977 across 2 operators and 0.949 across 2 radiologists | Low for good agreement |
Myelogram | All key outcomes | 0 or 1 study79 | Insufficient data | Insufficient |
Tests | Accuracy, concordance | 0 or 1 study17,72,80,81 | Insufficient data | Insufficient |
Tests | Over-or under treatment, clinical impact | 0 studies | No data | Insufficient |
Diagnostic Test . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
MRI | Sensitivity | 5 studies15–18,78 | Reported sensitivity ranged from 99% (no corresponding specificity) to 62% (corresponding specificity 61%) | Moderate for medium to high sensitivity |
Ultrasound | Sensitivity | 3 studies19,20,69 | Reported sensitivity ranged from 96% (corresponding specificity 96%) to 36% (corresponding specificity 100%) | Low for medium to high sensitivity |
Evoked Potentials | Sensitivity | 3 studies70–72 | Reported sensitivity ranged from 100% (no corresponding specificity) to 83% | Low for medium sensitivity |
MRI | Specificity | 4 studies15,17,18,78 | Reported specificity ranged from 100% (corresponding specificity 93%) to 61% (corresponding specificity 62%) | Moderate for medium to high specificity |
Ultrasound | Specificity | 3 studies19,20,69 | Reported specificity ranged from 96% (corresponding specificity 96%) to 84% (corresponding specificity 36%) | Moderate for medium to high specificity |
Evoked potentials | Specificity | 2 studies71,72 | Reported specificity ranged from 97% (corresponding sensitivity 83%) to 74% (corresponding sensitivity 88%) | Low for medium specificity |
MRI | Rater agreement | 1 study17 | κ between 2 evaluators was 0.94 | Insufficient |
Ultrasound | Rater agreement | 2 studies73,74 | ICC ranged from 0.977 across 2 operators and 0.949 across 2 radiologists | Low for good agreement |
Myelogram | All key outcomes | 0 or 1 study79 | Insufficient data | Insufficient |
Tests | Accuracy, concordance | 0 or 1 study17,72,80,81 | Insufficient data | Insufficient |
Tests | Over-or under treatment, clinical impact | 0 studies | No data | Insufficient |
ICC, intraclass correlation coefficient.
See details and references for all studies and reasons for downgrading the SoE in the Supplemental Information.
Key Question 2. Prophylactic Surgery for Asymptomatic Patients
We identified 8 studies that provided some information on the effects of prophylactic surgery. The studies were conducted in 6 countries, with 2 studies each from the United States and Japan. Sample sizes ranged from 41 to 354 patients, but the subgroups of asymptomatic patients were small. The studies included patients of different ages, and the oldest participant was 17. In this small set of studies, selection bias was suspected in several studies. The applicability issues included narrow eligibility criteria for patients, short follow-up times, and a suspected different level of care from current US standards. The study authors evaluated prophylactic surgical detethering approaches, such as in the context of scoliosis correction, or assessed other questions, such as the postoperative duration of the horizontal decubitus position. The studies compared the results of no surgery, delayed surgical detethering, or a different surgical intervention.
Table 2 contains a summary of the results for all key outcomes. The authors of 5 studies reported on neurologic status, and most studies reported that patients remained stable at follow-up after prophylactic surgery, but with few exceptions did not present equivalent data on the control group (eg, conservative observation).22 One study reported benefits for urologic function after concomitant prophylactic detethering, compared with no detethering or detethering before scoliosis surgery.23 The authors of 6 studies reported on post-operative complications. This included a study revealing an increased risk of surgical site infection with concomitant detethering compared with no detethering or detethering before scoliosis surgery (P = .01).2 Two studies revealed that one-third of patients experienced a surgical complication, and the remaining study authors reported on individual adverse events. SoE was low for all statements because the authors of no 2 studies reported on the same outcome measure, there were insufficient data to compute effect sizes, and data were based on observational studies with suspected selection bias. We identified no data on other key outcomes, including the need for repeat surgery.
Intervention . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
Prophylactic surgery | Neurologic status | 5 studies21–23,39,76 | One study revealed benefits in gross motor function associated with microsurgery compared with treatment as usual (follow up 72 mo); the others indicated that all patients remained stable during the follow-up (mean 68 mo) after prophylactic surgery (with insufficient data for the control group); that no asymptomatic infant deteriorated postoperatively, and 93% of children remained symptom-free at follow-up (mean 44 mo); that 0.7% of patients displayed deterioration after surgery (mild sensory disturbance) and 4.3% of patients managed with observation presented with varus (mild) but the other 95.7% had stable neurological states; or that no change in motor/sensory function occurred in any treatment group (follow up 3 mo, RR 4.62; CI 0.30-72.01). | Low for benefit |
Prophylactic surgery | Bladder or bowel function | 3 studies23,39,76 | One study revealed benefits for urologic function after concomitant prophylactic detethering compared with no detethering or detethering before scoliosis surgery (RR 13.85; CI 1.49–129.17);23 the others reported that no asymptomatic infant deteriorated post-operatively and that 93% of children remained symptom free at follow up (mean 44 mo, control group data unclear);39 and that urinary retention was seen in 0.7% of patients postoperatively but the deficit resolved after a few weeks (with no data on the observation control group). | Low for benefit |
Prophylactic surgery | Post-operative complications | 6 studies | One study revealed an increased risk of surgical site infection with concomitant detethering, compared with no detethering or detethering before scoliosis surgery (P = .01); one that 33% of patients experienced a surgical complication compared with no complication without surgery;22,23 another that 33% of patients undergoing untethering surgery experienced a complication.75 One study reported no CSF leaks;58 one no cases of abscess formation or meningitis;39 and another no operative mortality.47 | Low for complications |
Prophylactic treatment | Need for repeat surgery, Symptom score, ambulation, quality of life, pain, no. with adverse events | 0 or 1 study47 | Insufficient data | Insufficient |
Intervention . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
Prophylactic surgery | Neurologic status | 5 studies21–23,39,76 | One study revealed benefits in gross motor function associated with microsurgery compared with treatment as usual (follow up 72 mo); the others indicated that all patients remained stable during the follow-up (mean 68 mo) after prophylactic surgery (with insufficient data for the control group); that no asymptomatic infant deteriorated postoperatively, and 93% of children remained symptom-free at follow-up (mean 44 mo); that 0.7% of patients displayed deterioration after surgery (mild sensory disturbance) and 4.3% of patients managed with observation presented with varus (mild) but the other 95.7% had stable neurological states; or that no change in motor/sensory function occurred in any treatment group (follow up 3 mo, RR 4.62; CI 0.30-72.01). | Low for benefit |
Prophylactic surgery | Bladder or bowel function | 3 studies23,39,76 | One study revealed benefits for urologic function after concomitant prophylactic detethering compared with no detethering or detethering before scoliosis surgery (RR 13.85; CI 1.49–129.17);23 the others reported that no asymptomatic infant deteriorated post-operatively and that 93% of children remained symptom free at follow up (mean 44 mo, control group data unclear);39 and that urinary retention was seen in 0.7% of patients postoperatively but the deficit resolved after a few weeks (with no data on the observation control group). | Low for benefit |
Prophylactic surgery | Post-operative complications | 6 studies | One study revealed an increased risk of surgical site infection with concomitant detethering, compared with no detethering or detethering before scoliosis surgery (P = .01); one that 33% of patients experienced a surgical complication compared with no complication without surgery;22,23 another that 33% of patients undergoing untethering surgery experienced a complication.75 One study reported no CSF leaks;58 one no cases of abscess formation or meningitis;39 and another no operative mortality.47 | Low for complications |
Prophylactic treatment | Need for repeat surgery, Symptom score, ambulation, quality of life, pain, no. with adverse events | 0 or 1 study47 | Insufficient data | Insufficient |
CI, confidence interval; CSF, cerebrospinal fluid; RR, risk ratio.
See details and references for all studies and reasons for downgrading the SoE in the Supplemental Information.
Key Question 3. Treatments for Symptomatic Patients
We identified 38 studies addressing symptomatic tethered spinal cord treatment. The studies were conducted in 15 countries, with the largest group being US-based studies. Most studies were small, but sample sizes ranged from 6 to a large retrospective review of 6457 patients.24 The studies included patients of different ages, but most studies exclusively used pediatric samples. Several studies were rated as having a high risk for bias because of suspected selection bias in which participants were not randomly assigned to treatments but were followed in observational cohorts. Multiple studies were flagged in areas for deviating from standard clinical practice in the United States. The selected studies also had issues such as addressing more complex patients than those who are typical in clinical practice.
The authors of most of the identified studies evaluated surgical detethering approaches. Of these, some evaluated combining cord release with other surgical interventions versus a sequential approach,25–31 comparing surgical techniques such as laminectomy versus laminoplasty,32 laminectomy versus the drainage approach,33 duraplasty versus primary dural closure,34 laminoplasty versus hemilaminectomy,35 microsurgery versus open surgery,36–38 untethering with or without a laser,39 or complete versus incomplete detethering.40
One study compared detethering surgery and spine-shortening osteotomy,41 and another compared detethering and spinal fusion in a large retrospective review.24 Other studies compared surgery with the outcomes of patients who declined surgery or who were purposefully managed with standard medical treatment or observation.24,42–47 Other studies compared different timings of the intervention after diagnosis, for example, early surgery versus surgery after conservative treatment first or surgery in the first year of life versus later.22,48,49 The authors of some studies evaluated the incremental value of using intraoperative monitoring during surgery.50–52
A small set of studies addressed horizontal decubitus position after surgery, the ideal duration of or management with acetazolamide, or wound treatment approaches after detethering surgery.53–59 The strongest evidence base was identified for open surgical detethering. The identified studies revealed improved neurologic status compared with control groups (low SoE).32,41,76 However, open surgical detethering was associated with postoperative complications. Studies revealed cerebrospinal fluid leakage, in addition to other surgical complications22,31,32,34,36,41,42,47 (moderate SoE). Table 3 includes a summary of the results for all key outcomes. The SoE was low for all other statements because only single studies contributed to each evidence statement, there were insufficient data to compute effect sizes, and data were based on observational studies with a high risk of confounding. Despite the substantial number of identified studies, the authors of no studies reported on a priori-selected, patient-centered outcomes.
Intervention . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
Open surgical detethering | Neurologic status | 7 studies30,31,41,45,46,49,76 | One study compared detethered with cosmetic repair only and found a favorable effect (RR 9.78; CI 1.48, 64.41); one reported that children improved after detethering and after other spine corrections; another revealed that 20% of patients improved immediately after surgery, and worsening symptoms were seen in 9% but decreased to 6% at follow-up, whereas the 2 patients who were conservatively managed had stable neurologic status, one reported that 61% of operation (including repeat operations) resulted in clinical improvements and 33% left patients unchanged, while 50% of patients who had refused surgery experienced neurological deterioration; and one reported better motor function outcomes associated with cord release (RR 2.02; 0.40, 10.10). One study found more improvement in spine shortening surgery than detethering (P = .003). | Low for benefit |
Laminectomy vs laminoplasty | Neurologic status | 2 studies32,35 | Studies reported no difference in clinical improvement comparing laminectomy versus laminoplasty or that laminectomy compared with laminoplasty and hemilaminectomy was associated with poor or marginally improved surgical outcomes in a multivariate regression. | Insufficient |
Early surgical detethering | Neurologic status | 2 studies22,49 | Early surgery revealed benefits in neurologic symptoms compared with patients treated conservatively first before surgical management or compared with children with surgery after 1 year of age. | Low for benefit |
Combined surgery | Neurologic status | 3 studies25,33,39 | Combined approaches (eg, detethering and surgical drainage of the syrinx) resulted in more resolution of sensory deficits or were correlated with positive clinical outcomes, or 39% improved, 58% stabilized, and 3% worsened, indicating that detethering should be performed when addressing lipomas.39 | Low for benefit |
IOM during surgical detethering | Neurologic status | 3 studies50–52 | Neurologic progression was lower in the intraoperative monitoring group or achieved more complete recovery (RR 1.39; CI 1.01–1.90), while one study found no difference between groups (RR 1.00; CI 0.93-1.07) | Low for benefit |
TSC open detethering or spine shortening surgery | Bladder or bowel function | 11 studies29,31,39,41–45,47,49,77 | One study revealed effective rates for bladder dysfunction of 86% for complete release, 50% for partial release, and 33% for no release (RR 1.97; CI 0.39, 9.95); and the rates for defecation dysfunction were 93% for complete release, 57% for partial release, and 33% for no release; one study reported more satisfactory results for urinary tract dysfunction after laminectomy compared with no surgery (RR 1.94; CI 0.62-6.10); another small study revealed that 60% of patients reported continued urinary incontinence after surgery and 92% of patients without surgery reported urinary incontinence (RR 0.73; CI 0.48–1.11); pre-operative conservative medical treatment had to be continued in all operated children, and 67% of children without untethering remained continent in another study; one study revealed that 39% of children improved with untethering, whereas 93% of untreated patients remained symptom free at follow-up (mean 44 mo). Three studies reported no difference between treatment groups (no further data). Other studies reported improvement after surgery but no control group data. Urologic dysfunction occurred in 11% of a detethering and 50% of a spine shorting group (RR 0.22; CI 0.02-2.24). | Low for benefit for detethering surgery |
Combined debulking spinal lipoma plus detethering | Bladder or bowel function | 1 study39 | One study revealed that the combined surgery was effective, whereas cosmetic non-detethering procedures led to delayed postoperative deterioration. | Insufficient |
Open surgical detethering or spine shortening surgery | Ambulation | 3 studies41,47,49 | One study revealed similar gait ataxia scores between the detethered and control groups and one study reported that 2% of patients were wheelchair-bound after surgery but did not report frequencies in the control group.47 One study compared detethering with spine shortening and reported that gait disturbance improved in 50% in the detethering and 100% of the spine shortening group (N = 3, P = .39). | Insufficient |
Surgical detethering or spine shortening surgery | Pain | 5 studies29,38,41,42,44 | One study revealed that both patients operated on for back pain became symptom-free postoperatively, and 5% without surgical untethering reported increasing back pain. Two studies did not report on a control group. Another revealed that the mean time to pain relief was 3.21 mo across duraplasty and nonduraplasty. One study revealed that back pain improved in 20% of a detethering and 100% of a spine shortening group (N = 6, P = .12). | Low for benefit |
Open surgical detethering | Post-operative complications | 8 studies22,31,32,34,36,41,42,47 | Seven studies revealed cerebrospinal fluid leakage, in addition to other surgical complications, in the open detethering group. | Moderate for association with post operative complications |
Combined surgery | Post-operative complications | 5 studies26–28,30,39 | Combined surgery was associated with fewer complications in 2 studies; one study did not report any adverse neurologic events; and the others did not differentiate between treatment groups. | Low for fewer complications |
Minimally invasive detethering | Post-operative complications | 2 studies36,37 | One study revealed no postoperative complications in either group (RR 1.00; CI 0.07-14.34), and one study revealed that a pseudomenigocele developed in the minimally invasive detethering group, with no surgical combinations in the other. | Insufficient |
Laminotomy vs laminoplasty | Post-operative complications | 2 studies32,38 | One study revealed no difference in the number of early complications between laminotomy and laminoplasty (RR 0.25; CI 0.03, 1.99), another did not differentiate between treatment groups. | Insufficient |
IOM during surgical detethering | Post-operative complications | 4 studies50–52,59 | Intraoperative monitoring revealed statistically significantly fewer permanent surgery-related complications or new complications in 2 studies (RR 0.48; CI 0.24–0.96), whereas one study found no difference in the total 60-d complications, and one revealed that intraoperative monitoring was not associated with any complications and found no difference for wound dehiscence (RR 1.15; CI 0.07-17.84). | Low for fewer complications |
Position after detethering surgery | Post-operative complications | 3 studies54,56,58 | Maintaining patients flat did not prevent CSF leakage in 2 studies (one effect estimate RR 0.59; CI 0.05-6.41), one study reported none of the patients developed a CSF leak, regardless of the flat bed rest duration. | Low for no effect on cerebrospinal fluid leakage |
Treating CSF leaks after detethering surgery | Post-operative complications | 2 studies55,57 | A cystoperitoneal shunt compared to primary wound revision successfully resolved CSF leaks in one study (RR 0.11; CI 0.01, 0.78), while another study reported no difference between conservative and additional wound management, such as a ventriculoperitoneal shunt. | Insufficient |
Wound treatment after surgery | Post-operative complications | 1 study53 | One study revealed that the administration of acetazolamide, either alone or in combination with prone positioning, could not systematically lower complication rates (RR 0.43; CI 0.09, 2.09). | Insufficient |
Surgical detethering | Need for repeat surgery | 6 studies26,29,34,41,44,50 | One study each revealed that the intraoperative monitoring group was associated with a significantly lower rate of reoperation (P = .026) and that 2-stage patients reported a higher rate of repeat surgery versus a combined surgery group (RR 0.45; CI 0.05, 3.97). One study each reported that 11% of patients in the detethering surgery group underwent spinal shortening because of worsening symptoms and two studies found no statistically significant difference between symptomatic retethering for duraplasty versus primary dural closure (RR 4.43; CI 0.02, 77.24); and one study revealed that 15% of patients had signs of retethering after surgical detethering. | Insufficient |
Minimally invasive detethering | Neurologic status Ambulation | 0 or 1 study36,38 | Insufficient data | Insufficient |
TSC treatment | Symptom scores, 30 d complication rate, no. of adverse events | 0 studies | No data | Insuffient |
Intervention . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
Open surgical detethering | Neurologic status | 7 studies30,31,41,45,46,49,76 | One study compared detethered with cosmetic repair only and found a favorable effect (RR 9.78; CI 1.48, 64.41); one reported that children improved after detethering and after other spine corrections; another revealed that 20% of patients improved immediately after surgery, and worsening symptoms were seen in 9% but decreased to 6% at follow-up, whereas the 2 patients who were conservatively managed had stable neurologic status, one reported that 61% of operation (including repeat operations) resulted in clinical improvements and 33% left patients unchanged, while 50% of patients who had refused surgery experienced neurological deterioration; and one reported better motor function outcomes associated with cord release (RR 2.02; 0.40, 10.10). One study found more improvement in spine shortening surgery than detethering (P = .003). | Low for benefit |
Laminectomy vs laminoplasty | Neurologic status | 2 studies32,35 | Studies reported no difference in clinical improvement comparing laminectomy versus laminoplasty or that laminectomy compared with laminoplasty and hemilaminectomy was associated with poor or marginally improved surgical outcomes in a multivariate regression. | Insufficient |
Early surgical detethering | Neurologic status | 2 studies22,49 | Early surgery revealed benefits in neurologic symptoms compared with patients treated conservatively first before surgical management or compared with children with surgery after 1 year of age. | Low for benefit |
Combined surgery | Neurologic status | 3 studies25,33,39 | Combined approaches (eg, detethering and surgical drainage of the syrinx) resulted in more resolution of sensory deficits or were correlated with positive clinical outcomes, or 39% improved, 58% stabilized, and 3% worsened, indicating that detethering should be performed when addressing lipomas.39 | Low for benefit |
IOM during surgical detethering | Neurologic status | 3 studies50–52 | Neurologic progression was lower in the intraoperative monitoring group or achieved more complete recovery (RR 1.39; CI 1.01–1.90), while one study found no difference between groups (RR 1.00; CI 0.93-1.07) | Low for benefit |
TSC open detethering or spine shortening surgery | Bladder or bowel function | 11 studies29,31,39,41–45,47,49,77 | One study revealed effective rates for bladder dysfunction of 86% for complete release, 50% for partial release, and 33% for no release (RR 1.97; CI 0.39, 9.95); and the rates for defecation dysfunction were 93% for complete release, 57% for partial release, and 33% for no release; one study reported more satisfactory results for urinary tract dysfunction after laminectomy compared with no surgery (RR 1.94; CI 0.62-6.10); another small study revealed that 60% of patients reported continued urinary incontinence after surgery and 92% of patients without surgery reported urinary incontinence (RR 0.73; CI 0.48–1.11); pre-operative conservative medical treatment had to be continued in all operated children, and 67% of children without untethering remained continent in another study; one study revealed that 39% of children improved with untethering, whereas 93% of untreated patients remained symptom free at follow-up (mean 44 mo). Three studies reported no difference between treatment groups (no further data). Other studies reported improvement after surgery but no control group data. Urologic dysfunction occurred in 11% of a detethering and 50% of a spine shorting group (RR 0.22; CI 0.02-2.24). | Low for benefit for detethering surgery |
Combined debulking spinal lipoma plus detethering | Bladder or bowel function | 1 study39 | One study revealed that the combined surgery was effective, whereas cosmetic non-detethering procedures led to delayed postoperative deterioration. | Insufficient |
Open surgical detethering or spine shortening surgery | Ambulation | 3 studies41,47,49 | One study revealed similar gait ataxia scores between the detethered and control groups and one study reported that 2% of patients were wheelchair-bound after surgery but did not report frequencies in the control group.47 One study compared detethering with spine shortening and reported that gait disturbance improved in 50% in the detethering and 100% of the spine shortening group (N = 3, P = .39). | Insufficient |
Surgical detethering or spine shortening surgery | Pain | 5 studies29,38,41,42,44 | One study revealed that both patients operated on for back pain became symptom-free postoperatively, and 5% without surgical untethering reported increasing back pain. Two studies did not report on a control group. Another revealed that the mean time to pain relief was 3.21 mo across duraplasty and nonduraplasty. One study revealed that back pain improved in 20% of a detethering and 100% of a spine shortening group (N = 6, P = .12). | Low for benefit |
Open surgical detethering | Post-operative complications | 8 studies22,31,32,34,36,41,42,47 | Seven studies revealed cerebrospinal fluid leakage, in addition to other surgical complications, in the open detethering group. | Moderate for association with post operative complications |
Combined surgery | Post-operative complications | 5 studies26–28,30,39 | Combined surgery was associated with fewer complications in 2 studies; one study did not report any adverse neurologic events; and the others did not differentiate between treatment groups. | Low for fewer complications |
Minimally invasive detethering | Post-operative complications | 2 studies36,37 | One study revealed no postoperative complications in either group (RR 1.00; CI 0.07-14.34), and one study revealed that a pseudomenigocele developed in the minimally invasive detethering group, with no surgical combinations in the other. | Insufficient |
Laminotomy vs laminoplasty | Post-operative complications | 2 studies32,38 | One study revealed no difference in the number of early complications between laminotomy and laminoplasty (RR 0.25; CI 0.03, 1.99), another did not differentiate between treatment groups. | Insufficient |
IOM during surgical detethering | Post-operative complications | 4 studies50–52,59 | Intraoperative monitoring revealed statistically significantly fewer permanent surgery-related complications or new complications in 2 studies (RR 0.48; CI 0.24–0.96), whereas one study found no difference in the total 60-d complications, and one revealed that intraoperative monitoring was not associated with any complications and found no difference for wound dehiscence (RR 1.15; CI 0.07-17.84). | Low for fewer complications |
Position after detethering surgery | Post-operative complications | 3 studies54,56,58 | Maintaining patients flat did not prevent CSF leakage in 2 studies (one effect estimate RR 0.59; CI 0.05-6.41), one study reported none of the patients developed a CSF leak, regardless of the flat bed rest duration. | Low for no effect on cerebrospinal fluid leakage |
Treating CSF leaks after detethering surgery | Post-operative complications | 2 studies55,57 | A cystoperitoneal shunt compared to primary wound revision successfully resolved CSF leaks in one study (RR 0.11; CI 0.01, 0.78), while another study reported no difference between conservative and additional wound management, such as a ventriculoperitoneal shunt. | Insufficient |
Wound treatment after surgery | Post-operative complications | 1 study53 | One study revealed that the administration of acetazolamide, either alone or in combination with prone positioning, could not systematically lower complication rates (RR 0.43; CI 0.09, 2.09). | Insufficient |
Surgical detethering | Need for repeat surgery | 6 studies26,29,34,41,44,50 | One study each revealed that the intraoperative monitoring group was associated with a significantly lower rate of reoperation (P = .026) and that 2-stage patients reported a higher rate of repeat surgery versus a combined surgery group (RR 0.45; CI 0.05, 3.97). One study each reported that 11% of patients in the detethering surgery group underwent spinal shortening because of worsening symptoms and two studies found no statistically significant difference between symptomatic retethering for duraplasty versus primary dural closure (RR 4.43; CI 0.02, 77.24); and one study revealed that 15% of patients had signs of retethering after surgical detethering. | Insufficient |
Minimally invasive detethering | Neurologic status Ambulation | 0 or 1 study36,38 | Insufficient data | Insufficient |
TSC treatment | Symptom scores, 30 d complication rate, no. of adverse events | 0 studies | No data | Insuffient |
CI, confidence interval; CSF, cerebrospinal fluid; IOM, intraoperative monitoring; RR, risk ratio, TSC, tethered spinal cord.
See details and references for all studies and reasons for downgrading the SoE in the Supplemental Information.
Key Question 4. Treatment of Retethering
We identified 3 studies addressing the treatment of retethering. The studies were conducted in the United States and Germany. The oldest participant was 26 years old (when specified).40 Selection bias was identified as an issue in all retethering studies. The potential for reporting bias was also a concern in this small set of studies, which had short follow-up times and lacked numerical data for central outcomes. Applicability was limited in 1 because the patient sample composition did not reflect the full range of patients.
The studies compared vertebral column shortening versus revision detethering,60 complete versus incomplete detethering during cord release,40 and bilateral dural incision undercutting versus the conventional dural midline approach.61
Table 4 includes a summary of the outcomes of different interventions. The authors of 2 studies reported improvement in neurologic status after surgical detethering (low SoE) but reported no data on the control group or did not detect a statistically significant difference between groups.40,61 One study revealed that 50% of patients had improved urinary function after spinal column shortening, whereas 75% of patients had worsened bowel and bladder function after revision detethering.60 One study revealed improvement in bladder dysfunction in 26% of patients after repeat detethering (no data on the comparator group).61 One study revealed that 75% of patients reported improved pain after spinal column shortening.60 The SoE was insufficient for multiple outcomes when no study was identified in which the authors reported on the outcome of interest.
Intervention . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
Surgery | Neurologic status | 2 studies40,61 | One study revealed improvements in a variety of symptoms in 26% of patients undergoing lateral dura opening, but the corresponding results of the control group are not known, and one study revealed improved motor outcomes in patients with complete circumferential detethering, but many patients who underwent incomplete untethering still had positive outcomes, with no statistical difference between groups. | Low for benefit of repeat detethering |
Spinal column shortening | Neurologic status | 1 study60 | One study revealed no patients with worsening of lower extremity strengths after spinal column shortening versus 25% of patients reported worsening after revision detethering. | Insufficient |
Surgical detethering or spinal column shortening | Bladder or bowel function | 2 studies60,61 | One study revealed that 50% of patients had improved urinary function after spinal column shortening, whereas 75% of patients had worsening of bowel and bladder function after revision detethering, and one study revealed that 26% of patients showed improvement in bladder dysfunction after repeat detethering (no data on the comparator group). | Low for benefit of surgery |
Surgery | Pain | 2 studies60,61 | One study revealed that 75% of patients reported improved pain after spinal column shortening, and one study revealed a small number of patients with improved pain after tethered cord release, but no information was given on the comparators. | Low for benefit of surgery |
Surgery | Post-operative complications | 1 study60 | One study revealed no complications in 8 spinal column shortening patients but 3 wound-related complications in 8 patients with revision detethering (2 CSF leaks, 1 wound infection). | Insufficient |
Treatment | Ambulation, quality of life, 30-d complication rate, no. with adverse events, need for repeat surgery | 0 studies | No data | Insufficient |
Intervention . | Outcome . | No. of Studies . | Key Results . | SoE . |
---|---|---|---|---|
Surgery | Neurologic status | 2 studies40,61 | One study revealed improvements in a variety of symptoms in 26% of patients undergoing lateral dura opening, but the corresponding results of the control group are not known, and one study revealed improved motor outcomes in patients with complete circumferential detethering, but many patients who underwent incomplete untethering still had positive outcomes, with no statistical difference between groups. | Low for benefit of repeat detethering |
Spinal column shortening | Neurologic status | 1 study60 | One study revealed no patients with worsening of lower extremity strengths after spinal column shortening versus 25% of patients reported worsening after revision detethering. | Insufficient |
Surgical detethering or spinal column shortening | Bladder or bowel function | 2 studies60,61 | One study revealed that 50% of patients had improved urinary function after spinal column shortening, whereas 75% of patients had worsening of bowel and bladder function after revision detethering, and one study revealed that 26% of patients showed improvement in bladder dysfunction after repeat detethering (no data on the comparator group). | Low for benefit of surgery |
Surgery | Pain | 2 studies60,61 | One study revealed that 75% of patients reported improved pain after spinal column shortening, and one study revealed a small number of patients with improved pain after tethered cord release, but no information was given on the comparators. | Low for benefit of surgery |
Surgery | Post-operative complications | 1 study60 | One study revealed no complications in 8 spinal column shortening patients but 3 wound-related complications in 8 patients with revision detethering (2 CSF leaks, 1 wound infection). | Insufficient |
Treatment | Ambulation, quality of life, 30-d complication rate, no. with adverse events, need for repeat surgery | 0 studies | No data | Insufficient |
CSF, cerebrospinal fluid.
See details and references for all studies and reasons for downgrading the SoE in the Supplemental Information.
Discussion
With our review, we identified a large volume of research and addressed 4 critical questions relevant to patients with tethered spinal cords. This review provides a comprehensive dataset to support clinicians and researchers and documents remaining research gaps.
Because accurate and timely diagnosis is critical, clinicians aim to use tests associated with the highest sensitivity, specificity, and accuracy rates in clinical diagnostic tests. Our systematic review assessed the accuracy of diagnostic tests commonly used for patients with suspected tethered spinal cords. The identified studies evaluated MRI, ultrasound, CT, myelography, evoked potentials, urodynamic studies, and intraoperative neurophysiological monitoring in diagnosing tethered spinal cords. MRI had the strongest evidence base, with medium SoE for medium to good sensitivity and medium SoE for medium to good specificity. Ultrasound had low SoE for medium to good sensitivity and moderate SoE for medium to good specificity. On the other hand, both myelography and evoked potentials had low SoE for medium sensitivity and low SoE for medium specificity. There are several limitations to our analysis. First, the authors of most identified studies did not report diagnosis accuracy estimates such as sensitivity, specificity, or area under the curve. SoE was downgraded because of imprecision and inconsistency, given the lack of diagnostic effect estimates or range of reported results across studies and the absence of replication of results, thereby limiting the conclusions that can be drawn.
One of the most important considerations in tethered spinal cords is determining how best to manage asymptomatic patients, and a critical issue for clinicians and patients is how best to follow asymptomatic patients to detect any neurologic progression. Important considerations include the frequency of interval clinical assessments and the timing and type of diagnostic tests to triage patients. Historical clinical experiences suggest that many asymptomatic patients can develop irreversible neurologic injuries resulting in motor or sensory loss or bowel or bladder dysfunction. However, if prophylactic surgical treatment is pursued when patients are asymptomatic, patients and clinicians need to weigh surgically induced injury and adverse events. Most of the studies identified in this review included no asymptomatic patients or had a mixture of symptomatic and asymptomatic patients. Few studies were devoted to studying the benefits and harms of prophylactic surgery. Although predominantly suggesting benefits, sample sizes were small, and SoE was low.
In evaluating the effectiveness, comparative effectiveness, and harms of surgical and non-surgical treatments for patients with symptomatic tethered spinal cords, our review revealed that most studies revealed favorable outcomes associated with the surgical treatment of tethered spinal cords. Neurologic status was mostly improved after surgery, compared with no intervention. Early surgery is associated with more favorable neurologic outcomes in patients who are mildly symptomatic and diagnosed early on in their disease course. Conversely, surgery was associated with increased surgical risks, including infection, cerebrospinal fluid leaks, and wound complications, compared with non-surgical treatment. A significant limitation of many studies was the lack of a comparative analysis with a control group. In addition, sample sizes were small for many of the studies reviewed.
Even with improvement from prophylactic surgery or early detethering surgery, patients can develop recurrent tethered cord syndrome that leads to progressive neurologic and functional decline. In patients with recurrent tethering, a critical concern is weighing the benefits, harms, and long-term outcomes of another surgery compared with no treatment. Our systematic review revealed benefits, including in the areas of neurologic status, bowel and bladder functioning, and pain improvement, associated with revision detethering surgery. There was a lack of studies in which authors reported other important outcomes, including the number of patients with adverse events or the need for additional repeat surgeries.
With our systematic review, we have established a large and unique collection of relevant research on tethered spinal cords. It is based on a comprehensive literature search in multiple databases and research registries, incorporating input from the published literature and additional data provided by study authors. More than 450 studies contribute to this review and document the relevant research undertaken to support patients with suspected or confirmed tethered spinal cords.
In the review, we also identified the limitations of the research on tethered spinal cords. The current state of knowledge and the available data have many uncertainties. These are reflected in the wide variation in clinical practices in the community and clinical guidance is missing. To date, the Congress of Neurologic Surgeons has published guidelines for pediatric myelomeningocele;62 guidelines by the National Institute for Health and Care Excellence on open prenatal repair for open neural tube defects in the fetus63 and on fetoscopic prenatal repair for open neural tube defects in the fetus are also available.64 In addition, a guideline published by the Spina Bifida Association,65 the European Association of Urology/European Society for Pediatric Urology guidelines on the management of neurogenic bladder in children and adolescents,66 guidelines by the International Children’s Continence Society on tethered cord syndrome in occult spinal dysraphism,67 and an expert consensus document on best practices to minimize wound complications after complex tethered spinal cord surgery are available.68 However, the existing guidelines are related to the diagnosis or high association with tethered cord but do not constitute clinical practice guidance for the diagnosis or treatment of tethered spinal cord. A planned Congress of Neurologic Surgeons guideline will address an important gap in clinical practice.10 Additionally, the current review indicates that although there are data to support the current practice to diagnose, triage, and treat patients with tethered cords, there is a significant gap and need for better clinical research, with comparative studies with well-defined and measurable outcomes.
Improved reporting and concurrently controlled studies are urgently needed to advance the evidence base for this important clinical condition. Although we found numerous studies in which the authors reported on experience with a diagnostic modality, the reporting of diagnostic accuracy outcomes was lacking. Despite the importance of the outcomes, we identified no treatment studies in which the authors reported on key outcomes such as the number of participants with adverse events, and the available research for many other important outcomes was also insufficient to derive any evidence statements. Similarly, we identified hundreds of case series in which the authors reported on patients with tethered spinal cords. However, reporting within these studies was sparse, and limitations related to study design, in particular the lack of control or comparator information and the frequent lack of numerical outcome data for the complete sample, provided little information that can be adapted to clinical practice recommendations.
The authors of the existing research need to improve studies by including a control or comparison group. A tethered spinal cord is a progressive disease, and single-arm studies cannot distinguish the effects of the intervention from the natural course of the disease. The authors of diagnostic accuracy studies should clearly report on the performance of a test compared with a reference standard. For treatment studies, assignment to treatments not based on patient characteristics, such as randomized controlled trials, are needed to formulate stronger evidence statements. Ideally, the authors of randomized controlled trials would stratify tethered cord patients with similar degrees of neurologic impairment. Such studies might yield results that address the question of whether surgery or non-surgical treatments are better for tethered cord patients. Alternatively, large prospective observational studies that closely follow asymptomatic and symptomatic tethered cord patients with quantitative outcome measures and neurologic assessments would provide valuable information on the natural history and risk of progression for these patients.
Despite the documented use of and clinical experience with common diagnostic procedures in case series for tethered spinal cords, many open questions remain, particularly those related to the accuracy of these modalities. Our review revealed limited relevant data on diagnostic modalities beyond MRI and ultrasound. The authors of future research should more thoroughly investigate the different options available for patients to further refine diagnostic accuracy.
The authors of future research should report outcomes, including adverse events, quantitatively and systematically. For all key questions, experts advised on the key outcomes, and, despite the research volume, there was insufficient evidence for a number of outcomes. For tests used to diagnose a tethered spinal cord, we found no studies in which the authors reported information on over- or undertreatment or any clinical impact of using the diagnostic modality. For prophylactic surgery, we have no data on the effects on symptom scores, ambulation, quality of life, pain, the number of patients reporting adverse events, and the need for repeat surgery. Despite the large number of treatment studies evaluating interventions in symptomatic patients, we did not identify a study in which the authors reported on a standardized scale to assess relevant tethered spinal cord symptoms. Although we identified studies in which the authors reported on some postoperative complications, the authors of this small number of studies reported some conflicting results, and more research is needed for definitive evidence statements. The evidence base for addressing spinal cord retethering was insufficient for many expert-identified patient-centered outcomes that could guide clinical practice, despite the importance of the outcomes, indicating the need for more research. In general, greater emphasis is needed on reporting on patient-centered outcomes, such as ambulation or renal function preservation, which are key considerations for patients that could affect their decision to undergo surgical detethering.
Acknowledgments
We thank David Bauer, Azniz Bane, Daniel Donoho, Judy Thibadeau, Linda Bambrick, Eisha Christian, Wende Gibbs, Steven Hwang, Stephanie Kielb, Yogi Matharu, Justin Lantz, Robin Bowman, Lionel Banez, and Jennie Dalton for helpful comments. We thank Saad Ali, Haluk Altiok, Joshua Chern, Shlomi Constantini, Michael Fehlings, Toshiaki Hayashi, Fritz Karrer, Marc Levitt, Jonathan Norton, Vedantam Rajshekhar, Paul Steinbock, Goichiro Tamura, Adrian Elmi Terander, and Seow Wan Tew for assistance with the dataset. We thank Bob Bentz, Kevin Blythe, and Jeremy Miles for assistance with the analysis.
Drs Hempel and Hsieh designed the review; Drs Apaydin and Briggs contributed critical appraisal; Dr Al-Amodi, Ms Aleman, Ms Dubel, Ms Sardano, Ms Saint-Val, Ms Sysawang, and Ms Zhang screened and abstracted data; Ms Yagyu designed the searches; Ms Motala and Ms Tolentino obtained data and managed the literature flow; and all authors made critical contributions to the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.
The findings and conclusions in this article are those of the authors, who are responsible for its contents. They do not necessarily represent the views of AHRQ or PCORI. Therefore, no statement in this manuscript should be construed as an official position of AHRQ or PCORI.
This article has been registered with PROSPERO (identifier CRD42023461296).
FUNDING: This project was funded under contract 75Q80120D00009/75Q80123F32004 from the Agency for Healthcare Research and Quality (AHRQ), the US Department of Health and Human Services (HHS), and the Patient Centered Outcomes Research Institute (PCORI). Dr Apaydin was supported by a VA HSR Career Development Award (IK2X003534). The authors of this document are responsible for its content. The content does not necessarily represent the official views of or imply endorsement by the AHRQ, HHS, or PCORI.
CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no potential conflicts of interest relevant to this article to disclose.
Comments